A critical review of the original literature has been made to identify drugs and other substances which interfere chemically with clinical laboratory test procedures. The nature and extent of such interference has been correlated with particular methods of analysis.
Medications may alter laboratory test values through a variety of pharmacological, physical or chemical mechanisms. Phal/macologically, a drug may cause a true change in the concentration of the particular substance being measured. Thus, allopurinol, a xanthine oxidase inhibitor, is used to reduce plasma uric acid levels in selected patients. Incidental pharmacologic effects, other than those primarily intended, may also occur. Antiovulatory drugs, used for contraceptive purposes, cause an increase in total serum thyroxine-binding globulin. This results in an increase in both total serum thyroxine and unsaturated thyroxine-binding globulin, but no significant change in unbound ("free") thyroxine. Recognition of these effects is essential in the interpretation of thyroid function tests. Drugs may also cause undesirable toxic or side effects, as evidenced by changes in liver or renal function tests. Thus, in some individuals, phenothiazines will produce a picture of obstructive jaundice, with elevation in serum bilirubin and alkaline phosphatase. Knowledge of the pharmacologic effects of drugs helps to explain a number of correct but otherwise unexpected laboratory results. Several reviews, dealing primarily with such changes, have appeared recently1-3.
drugs can interfere by producing extraneous color reactions, by chelation, or by inhibition of enzyme activity.
In addition to chemical interferences by drugs, one should also consider the effects of anticoagulants and of marked changes in concentrations of normally occurring substances in body fluids which alter laboratory test values. Hemolysis, lipemia, and elevated serum bilirubin interfere in a number of procedures. In uremia, associated high levels of creatinine and uric acid can result in falsely elevated values for glucose as measured by alkaline ferricyanide methods.
Chemical interferences arise primarily from lack of specificity of the methods used to measure desired constituents. The usual methods of quality control, such as including a control serum or standard with each series of determinations, will not detect errors arising from some interfering substance in one of the unknowns. This problem of specificity is an area of special concern to the clinical chemist.
In 1968, Elking and Kabat4 tabulated over 1500 citations relevant to druginduced modifications of laboratory test values. Garb5, in a recent book, includes this and additional information in handy tabular form. Martine, in his text, also includes tables on drug interference with clinical laboratory tests. These valuable contributions list the effects of drugs as resulting either in an elevated (or false positive) value or a decreased (or false negative) value but do not distinguish, for the most part, between pharmacologic effects and chemical interferences. An exception is the work of HanstenT, who presents discussions concerning the effects of drugs on clinical laboratory test values and distinguishes those in which the effect is due to interference with the testing procedure.
Another problem is to determine whether a reported drug interference was observed at realistic concentrations which are likely to occur in serum or urine during a typical therapeutic regimen. We have found, for example, that methyldopa, in concentrations of IO mg/dl, will cause spurious elevations of results obtained in the determination of uric acid. The usual dosage schedule for methyldopa, however, leads to plasma concentrations of approximately 0.2 mg/dl and urine concentrations of approximately IO-z5 mg/d18. At these levels, interference with determinations on urine is substantial but for serum it is insignificant.
Several approaches have been used to investigate the effects of drugs on laboratory test values. Naumann9 studied the effect of a single drug, phenazopyridine (Pyridium), on a number of procedures. O'Kell et aLIO added antibiotics to serum to approximate levels likely to be encountered in patients and found no interference in IZ automated methods of analysis. Singh et al.ll , analyzed solutions of 45 medications, at I mmole/liter concentrations, on the Technicon SMA 12/60 and found significant interference from 25. Of these, 8 showed significant interference at concentrations likely to occur in plasma after a single maximum therapeutic dose. With a screening battery of g tests, Van Peenen and Files I2 found negligible differences in test results from a series of 2500 patients either receiving or not receiving 42 commonly administered medications. These findings, of course, apply only to the test procedures and medications studied. Cryer and Sode13 investigated a number of analgesics and tranquilizer-sedatives to determine those which could be used during diagnostic evaluation of adrenal function without pharmacologic or chemical alteration of urinary hormonal values. Borushek and Gold14, in a classic study, determined the effects of 23 drugs on values for urinary IT-ketosteroids and r7-hydroxycorticosteroids.
These drugs were C&n. Chinz. Acta, 41 (rgp) tested in pure solution and in combination with pure standards. In addition, they were administered to patients to determine the change in test values on z4-hour urine collections. All of these various approaches have merit and could be expanded to include more medications and different methods of analysis.
In the present study, a critical review of the original literature has been made with respect to chemical interferences in clinical laboratory test procedures. Attention has been directed especially to the methods employed and, where possible, to the nature and extent of such interferences. Ready availability of this information should help to explain certain anomalous test results and stimulate development or adoption of more specific methods of analysis.
TABULATIONS
The information is arranged alphabetically according to test procedures. Subheadings, describing the analytical method affected, are followed by alphabetical listings of interfering substances. The latter are preceded by the notation (+) or (-) to indicate that the substance causes a false increase or false decrease, respectively, in test values. A substance reported to show no interference with the test is preceded by the notation (0) . References are given to the original literature, but no claim is made for complete coverage. Some selection in choice of citations has been exercised, when multiple observations in substantial agreement have been reported. In some cases, we have augmented the material with personal observations or experiments and these have been so indicated.
Interferences from bilirubin, hemoglobin, lipemic serum, color of urine, etc., cause obvious problems with various spectrophotometric or visual examinations. Chemical interferences from these sources have not been listed, unless special circumstances seemed to warrant them. Interferences from impurities in reagents or distilled water have not been included, with a few exceptions, inasmuch as these can normally be detected or corrected by inclusion of reagent blanks, standards, and recovery experiments.
Drugs are listed by generic name, followed, in some cases, by the more common brand name or names. This information has been taken from Facts and Comparisonsl5, updated to 1972. This publication is very convenient for such cross-referencing.
AMYLASE
The following anticoagulants are reported to reduce plasma amylase activity about 20% as compared to serum or heparinized plasma. (-) Citrate16 carbazone, the color change is from red to deep purplelQ. Our own observations are based on the latter procedure. (+) Chlordiazepoxide (Librium). We have observed false positives with toxic overdoses only.
(+) Chlorpheniramine lg. Interferes only at toxic levels (over 4 mg/dl). We have observed false positives in patients receiving the drug and in vitro at concentrations of IO mg/dl.
B. Ultraviolet s$ectrophotometric
methods based on absorbance readings at 239 nm at pH IO and on decrease in absorbance after acidification. (-) Salicylate. Extracted with barbiturates and shows an increase in absorbance after acidification. Suitable corrections can be madezl.
BILIRUBIN
A. Sewna bilirubin is determined by reacting it with diazotized sulfanilic acid to produce reddish-violet azobilirubin. In the Malloy-Evelyn method, the final mixture is acid and contains 50% methanol. A serum blank is included routinely.
(+) Dextran 22. Used as a plasma expander and produces turbidity in presence of methanol. Serum blanks tend to be variable and do not provide adequate correction.
(-) Hemoglobin 23. Nitrite converts hemoglobin to methemoglobin. Decreased values for bilirubin may be related to competition for nitrite between hemoglobin and sulf anilic acid.
B. Direct spectrophotometric estimation of biliwbin.
Readings are made at 2 wavelengths to correct for absorbance by hemoglobin. Single readings at one wavelength (usually 460 nm) are reported in terms of "icterus ind.ex".
(+) Carotene. This pigment is normally present in serum and appears in excess after ingestion of large amounts of carrots or other yellow-colored vegetables. (+) Hemoglobin.
Causes spurious elevation in icterus index, especially if readings are made at 420 nm rather than 460 nmz4. (+) Lipemia. Contributes to absorbance and is not corrected by reading at 2 wavelengths since the apparent absorbance of turbid solutions increases as wavelength is decreased. (+) Novobiocin.
A yellow lipochrome metabolite of the drug appears in plasmaZ5. C. Bilimbin ia wine is detected by reaction with an acidified diazonium compound, available in tablet or test strip form, to produce a blue to purple color (e.g., Ictotest, Ames Co.).
({-) Ethoxazene (Serenium). Colors the urine orange-red and may be misinterpreted as positive for bilirubin.
(+) Phenazopyri~ne (Pyridium). Colors the mine orange-brown and becomes reddish-brown in acid solution. May be misinterpreted as positive for bilirubin@.
BLOOD, OCCULT
This determination is done on urine or feces to detect amounts of bIood not grossly visible. Hemoglobin, myoglobin, and hematin exhibit peroxidase-hike activity which, in the presence of hydrogen peroxide effects oxidation of various substrates such as guaiac, benzidine, and o-tolidine to produce color. Peroxidases from other sources may be removed by boiling the specimen. Various tablets and reagent strips have been formulated to improve stability of the reagents. Sensitivity, effects of diet, and iron salt therapy have been reviewed26. Specimens collected in containers cleaned with bleach (hypochlorite) may turn reddish-brown immediately, giving a false impression of blood in the urine28. (+) Sulfobromophthalein (BSP). Alkaline stools may appear "bloody"but tests for occult blood are negativeas.
(-) Tetracyclines. Some preparations contain high concentrations of ascorbic acid as preservative. Large amounts in the urine inhibit color development.
BSP TEST
S~fobromophthal~in (BSP) is injected intravenously, usually in doses of 5 mg{kg of body weight, as a test of liver function. Blood is drawn after 45 min, and the serum made alkaline to develop the color of the remaining BSP. Increased values are observed in liver disease, due to failure of conjugation or excretion by the liver. (+) Anabolic steroids (e.g., norethandrolone). These appear to affect liver function as evidenced by concurrent increase in serum lactic dehydrogenase or bilirubin~331. Addition of cyanide overcomes interference43144.
CATECtIOLAMINES
A. In the screening method of Hingerty46, epinephrine and norepinephrine in urine are adsorbed on aluminum oxide at pH 8.4, eluted with dilute acid and oxidized with ferricyanide at pH 6.5. Addition of strongly alkaline ascorbate effects ring closure with formation of adrenochromes which produce a green fluorescence. In quantitative procedures, internal standards and sample blanks are included47. (+) Salicylates. Interference has been suggested58. We have added salicylate to serum to produce levels of IOO mg/dl and have found no interference when the iron reaction is applied to isopropanol extracts.
(-) Thiouracil. When used as a preservative at levels of 13 mg/dl, the apparent serum cholesterol was decreased by 30-40 mg/dlYO. (+) Tryptophan. Present in protein and produces a red color in the direct reaction when glyoxylic acid is present as a contaminant in acetic acid71. HenryT2 states that the top normal level of tryptophan in serum is about 3 mg/dl. In his method, I mg of tryptophan gave color equivalent to I mg of cholesterol. W7e have tested glacial acetic acid, containing IO g/liter of added glyoxylic acid, and have observed a decrease in apparent serum cholesterol values of approximately 40% when the iron-sulfuric acid reaction was applied either directly to serum or to isopropanol extracts. Addition of IO mg/dl of tryptophan to serum produced no detectable increase in the apparent cholesterol levels with either technique. In general, however, direct determinations on serum by the iron-sulfuric acid method gave higher results than when applied to extracts. This is probably a result of slight charring of protein during color development. (+) Vitamin A. Levels of 150 pg/dl in serum have been reported to increase the apparent cholesterol level by 100-150 mg/dl when the direct method is employed73. Subsequent reports have failed to confirm these findings~4.
CORTISOL, PLASMA
Cortisol is extracted into dichloromethane, washed with alkali, and mixed with ethanol-sulfuric acid. Fluorescence is measured after IO min. (+) Benzyl alcoho175. Some heparin solutions contain benzyl alcohol as preservative which reacts with an impurity in dichloromethane to produce a similar fluorescence. Interference is significant at IO min and increases markedly by 20 min. The dichloromethane should be spectral grade, or redistilled over concentrated sulfuric acid to eliminate interferenceT6. (+) Spironolactone 77. Fluorescence emission spectrum is identical to that of cortisol.
CREATININE
Creatinine reacts with picrate in alkaline solution to form a reddish-brown I : I adduct (Jaffe reaction). Complete color development requires 15-20 min at 25'. Kinetic methods have appeared based on the rate of color developmenV8. At elevated temperatures, picrate is reduced to reddish-brown picramate by glucose and other reducing substances. Efforts to improve specificity of the reaction have included ether extraction and/or preliminary treatment with iodine to remove interfering substances (ref. 79 ). Adsorption of creatinine on Fuller's earth or ion exchange resin has also been employed. Practically, the Jaffe reaction is usually applied directly to urine or proteinfree filtrates without preliminary treatment of specimens. A recent study, applied to urine, indicates that the original Jaffe reaction is the most specific of several procedures investigatedsO. We have evaluated some reported interfering substances by adding alkaline picrate to pure solutions, both in the presence and absence of creatinine. Reaction conditions in our studies were essentially those of Bonsnes and Taussky*l with color development for 15 min at 25". (+) Acetoacetic acid. Reaction with picrate occurs almost immediatelyT8. We find that IOO mg/dl of acetoacetic acid produces color equivalent to 3.4 mg/dl of creatinine. Color development was complete by I min.
(+) Acetone 82. We find that 500 mg/dl of acetone produces color equivalent to 1.4 mg/dl of creatinine. (+) Aminohippurates3. Produces a positive Jaffe reaction but does not interfere at the concentrations obtained during renal studies. (+) Ascorbic acid*&. Color development is ascribed to a reducing action. We find that 250 mg/dl of ascorbic acid produces color equivalent to 1.9 mg/dl of creatinine. This concentration could occur in urine but the interference is negligible. (+) Fructoses5. We find that IOOO mgjdl of fructose produces color equivalent to 1.0 mg/dl of creatinine after 15 min color development. Extension of incubation time results in marked increase in interference.
C&z. Chirn. Acta, 41 (1972) 395-434
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(+) G1ucoses2~80. Reaction appears negligible at 25". We find that IOOO ml/d1 of glucose produces color equivalent to only 0.2 mgjdl of creatinine. (+) ~~thyldopa. Autolridation in alkaline solution produces a brown color. We find that IO mgjdl of methyldopa produces color equivalent to 1.0 mg/dl of creatinine.
(+) Nitrofuran derivatives I. These produce a deep orange-brown color in urine specimens. (+) Phenolsulfonphthalein (PSI'). Color is produced in alkaline so1ution7s~87. Treatment with zinc in acid solution has been proposed to reduce BSP and PSP to leuco dyes which do not interfere. A separate alkalinized sample blank should also be satisfactory.
(+) Protein 89~88. We find that 5 g/d1 of crystalline human serum albumin produces color equivalent to 2.2 mg/dl of creatinine. (+) Pyruvate. Produces a positive Jaffe reaction. One mg of pyruvic acid is reported to produce color only slightly less than I mg of creatininess*90. We find that IO mgldl of pyruvic acid produces color equivalent to 0.3 mgidl of creatinine. protein-free filtrates of serum, followed by treatment with iodine and ether extraction.
ESTROGENS

A. The followiytg com$omds
weve found to interfere in a procedure described by Brown"2, based on fractionation of urinary estrogens and color development with a modified Kober reaction. An additional purification step was included in a subsequent modification that eliminated interference from all those listed93. The first reaction is highly specific for glucose and has been adapted for use with PO, electrodes. The second reaction is less specific; reducing substances either compete with the chromogen for H,Oz, or keep the chromogen in the reduced state, leading to low results. Somogyi filtrates are recommended to eliminate or minimize Produces an abnormal orange color and reduces the intensity of the green color usually produced by glucose in the o-toluidine reaction. (+) Hexoses. Galactose and mannose produce color equivalent to glucose. Fructose does not reactlo2. (+) Pentoses. These produce an orange color with the reagent. The reaction has been applied to measure xylose in urine. C. Ferricyanzide is reduced by glucose in hot alkaline solution to colorless ferrocyanide. The method is reasonably reliable when applied to dialysates of nonuremic serum, but is unsatisfactory for measurements on urine. We have observed increases in apparent glucose values with the following when analyzed in pure solutions. (+) Creatinine. I mg is equivalent to 1 mg glucose.
(+) Uric acid. I mg is equivalent to 0.5 mg glucose.
D. Copper-reductiolz methods.
Numerous modifications have been proposed. For whole blood glucose, a Somogyi filtrate provides greatest specificity. For serum glucose, a Folin+Wu filtrate is about equally satisfactory. Uric acid has been shown to produce color equivalent to 75% of glucose by the Folin-Wu method but no color with the Nelson-Somogyi method. Glucuronic acid, however, appears in substantial amounts in either filtratelo'.
The following interferences refer almost entirely to the measurement of total
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reducing substances in urine, either with Benedict's reagent or Clinitest tablets (Ames Co.). Such determinations are done primarily as semiquantitative tests for glucose in urine but are also helpful to detect pentosuria, lactosuria, etc., where glucose oxidase strips would be negative. Concentrations of reagents are adjusted to produce "negative" or trace reactions for reducing substances, such as creatinine and uric acid, normally present in urine. (+) Salicylatel22. Interfering fluorescence is caused by acetylsalicylic acid, salicylic acid and an unidentified metabolite. Blank readings are increased 50-100 fold.
IT-HYDROXYCORTICOSTEROIDS
This group of steroids (IT-OH) is commonly determined by the Porter-Silber reaction123~124. Following enzymatic hydrolysis with ,%glucuronidase, the free steroids are extracted into chloroform, washed with dilute alkali, then re-extracted into a strongly acid solution of phenylhydrazine. The absorbance of the yellow derivative is measured at 410 nm. (r7-Ketogenic steroids are discussed under r7-ketosteroids. See also cortisol, plasma).
The most extensive single study on drug interference in steroid dete~nations is that of Borushek and Gold14. Determinations were made in V&O on solutions of 23 drugs, both alone and in the presence of standards, and on 24-h urine collections from patients before and after receiving the medications. Observations reported include absorbance produced by the drug alone, increased or decreased absorbance of standard in the presence of the drug, and apparent increase or decrease in urinary steroid excretion following a~injstration of the drug. Only drugs showing the latter effect are included below. ( -) Propoxyphene (Darvon) 13. Administration of 195 mglday decreased apparent XT-OH excretion by 18%. This may be a pharmacologic effect since the drug had no effect in vitro.
(+) Quininelz7.
(-) Reserpine (Serpasil)14. This may be a pharmacologic effect since the drug produces an orange-red color in the final reaction mixture and contributes to absorbance.
(-) Salicylates Iso Following large doses, salicylate glucuronide in urine acts as a .
competing substrate for glucuronidase. Complete hydrolysis of conjugated steroids requires more enzyme and prolonged incubation times.
(+) Spironolactone (Aldactone) 13r. The drug or its metabolite produces a similar color reaction.
(+) Triacetyloleandomycin133.
Administration of I or 2 g/day increased apparent 17-OH excretion by 2 to 4-fold. Addition of 0.25 g to a 24-h urine specimen elevated the apparent value from 2.9 to 10.5 mg.
5-HYDROXYINDOLEACETIC ACID (5-HIAA)
A. Screening test on urine. A purple color is developed by reaction with Initroso-z-naphthol and nitrous acid la3. This reaction is said to be specific for 5-hy- (-) Formaldehyde.
Released from various drugs. Inhibits color development136.
(+) Glyceryl guaiacolate (Robitussin)134p137.
(-) Keto acids13*. Excessive amounts interfere with color formation. (-) Phenothiazines 140. Compounds inhibit color development.
B. Qua&tat&e tests.
Urine is treated with dinitrophenylhydrazine to remove keto acids. 5-HIAA is extracted, purified, and reacted with the same reagents as in the screening test. By the method of Udenfriend et a1.13*, metabolites of mephenesin, methocarbamol and glyceryl guaiacolate produce falsely elevated results. By permitting the final solution to stand to allow fading of some interfering colors, and by reading absorbance at two wavelengths, Mustala claims to have eliminated or detected interference from these compounds134~141.
IODINE UPTAKE, RADIOACTIVE
(See thyroid function tests.)
KETONE BODIES (URINE)
This category includes qualitative tests for acetone and acetoacetic acid (diacetic acid), and for phenylpyruvic acid.
A. Gerhardt test. .
I$'-KETOSTEROIDS AND IT-KETOGENIC STEROIDS
r7-Ketosteroids (17-KS) are commonly measured by some modification of the Zimmerman reaction. Following acid hydrolysis, the free steroids are extracted into a nonpolar solvent and washed with alkali. A portion of the extract is evaporated and the steroids reacted with m-dinitrobenzene in alcoholic alkaline solution. The absorbance, after development of the red-purple color, is measured at 520 nm. 3-Ketosteroids and zo-ketosteroids also react but produce less color than 17-KS.
r7-Ketogenic steroids (17-KGS) include the r7-hydroxycorticosteroids (discussed separately) as well as certain other steroids, such as pregnanetriol, with a 17-hydroxy, zo,zI-side chain. These compounds may be oxidized to 17-KS by treatment with sodium bismuthate in acetic acid solution, then measured by the usual Zimmerman reaction. Pre-existing 17-KS are determined separately and subtracted from the total to provide a measure of r7-KGS. In subsequent modifications, pre-existing 17-KS are eliminated by reduction with borohydride prior to bismuthate oxidationl49. Metaperiodate may be substituted for bismuthate as an oxidizing agent.
The following refer mainly to interferences encountered in actual urine specimens, rather than to reactions with pure drugs. 
LACTIC DEHYDROGENASE
This enzyme catalyzes the reaction :
Calorimetric assays using the pyruvate-to-lactate reaction and measuring the disappearance of pyruvate with the dinitrophenylhydrazine reaction will give low results if NADH is omitted from standard solutions of pyruvate. Pyridine nucleotides react with the reagent to yield a product which absorbs maximally at the same wavelength as pyruvate. The nucleotide competes for the color reagent with increasing effectiveness as the pyruvate concentration decreases during the reaction16°.
LIPASE
In the turbidimetric method of Vogel and ZievelG1, serum lipase activity is related to the decrease in absorbance observed during incubation of an olive oil emulsion.
(+) Bilirubin lfi2. Apparent lipase activity was shown to be elevated in proportion to the concentration of bilirubin. A titrimetric method was not affected. The interfering substance, presumably bilirubin, can be removed with DEAE cellulose.
MAGNESIUM
Magnesium reacts with Titan Yellow in alkaline solution to produce a pink complex which is measured spectrophotometrically. (-) G1uconate163. Administration as the calcium salt resulted in falsely low results by the Titan Yellow procedure but not in methods involving phosphate precipitation or preliminary ashing. The effect was confirmed in vitro.
METANEPHRINES (See catecholamines.)
PHOSPHATASE, ALKALINE
(+) Albumin infusions 164,165. Albumin prepared from human placentas contains heatstable alkaline phosphatase. In one case, the serum alkaline phosphatase rose to 160 Bodansky units after multiple infusions and remained elevated for IO days following cessation of therapy ls4. Manufacturers vary in whether or not they use only venous blood as a source of albumin lG6. The heat-stable enzyme may be detected by incubating serum at 60" for I h to destroy alkaline phosphatase of non-placental origin. (-) Albumin infusions. In contrast to the above, albumin prepared from venous Clin. Chim (-) Oxalate.
(-) Tartrate.
PORPHYRINS
A screening test for urinary coproporphyrins is performed by adding acetic acid to urine and extracting with ether. Coproporphyrins in the ether layer are detected by their pink fluorescence in ultraviolet light. (+) Phenazopyridine (Pyridium). Colors the urine orange-brown and is often mistaken for porphyrins. The interference is eliminated by adding a small amount of sodium dithionite (Na,S,O,) to the urine prior to extractiona.
A pink fluorescence is observed when both tetracycline and phenazopyridine are present together. Neither drug alone was found to interfere in the screening test.
PREGNANCY TESTS
These tests depend on the measurement of human chorionic gonadotropin (HCG) in urine in early pregnancy. Biologic pregnancy tests employ animals, such as frogs, rats, and rabbits. More recently, immunologic tests utilizing latex particles or erythrocytes, coated with HCG, and an antiserum to HCG have been developed. When these are mixed together, agglutination occurs. When HCG in the urine of a pregnant woman is added to the system the antiserum (anti-HCG) is neutralized and agglutination does not occur, Thus, agglutination-inhibition is interpreted as a positive test. Various commercial reagent kits and modifications are available. (+) Phenothiazines. False positive frog tests were reported in 8 of rg patients receiving promazine (Sparine) and in 5 of II patients receiving chlorpromazine (Thorazine). Use of serum, rather than urine, was recommendedlT2. One report describes a false positive immunologic test on urine from a patient receiving chlorpromazinel73. The test became negative z. weeks after the drug was withdrawn. At the time of the positive test, however, the patient also showed+ pro-teinuria which could be responsible for the false positive. In subsequent reports, false positive immunologic tests were attributed to phenothiazines for some reagent kitslT4; other investigators were unable to demonstrate either false positive or false negative results associated with phenothiazine medication17s. Release of luteinizing hormone (LH) or interstitial cell stimulating hormone (ICSH), following phenothiazine therapy, has been suggested as a possible mechanism for false positive pregnancy tests 176t177. Both hormones cross-react with anti-HCG. (+) Protein. A number of reports described false positive immunologic tests for pregnancy attributed to protein in urine 178-180. Presumably these were caused by contamination of commercial HCG preparations with other antigenic proteinslsl. 3 g ), the apparent serum albumin level was reported to decrease by 14%. (-) Sulfonamides. The mechanism is similar to that of salicylatelss.
PROTEIN (SERUM)
A
C. Electvophoresis of semin proteins. (&)
Iodinated radiographic contrast media. At serum levels expected during diagnostic studies, the peaks due to albumin and to cc-and P-globulins flatten or disappear. A high peak appears in the y-globulin region18*. (A) Penicillin. High doses, given intravenously, are reported to cause formation of bis-albunmilss. The penicillin-albumin complex has greater electrophoretic mobility than normal albumin.
PROTEIN (CEREBROSPINAL FLUID)
A. Twbidimetric methods based on addition of sulfosalicylic acid or trichloroacetic acid. Henry et al. have reported that albumin produces 2.4 times as much turbidity as globulin with sulfosalicylic acid reagent lge. With trichloroacetic acid, globulin produces about 20% greater turbidity than albumin. A mixed reagent was recommended.
Pennock et al.lsl recommend a mixture of sulfosalicylic acid and sodium sulfate with which the turbidity produced is independent of the relative concentrations of albumin and globulin. (+) Bilirubin. Absorbance due to bilirubin is especially significant near 460 nm. This can be minimized, but with some loss in sensitivity for turbidimetric measurements, by using wavelengths above 500 nm. In addition, a sample blank should be included for xanthochromic fluids. Quantitative methods are usually similar to the turbidimetric methods for cerebrospinal fluid. A suitable blank must be included to correct for absorbance by urinary pigments. The following observations pertain to qualitative tests for protein in urine.
A. Precipitatiopz of protein with sulfosalicyclic acid or trichloroacetic acid, or by heating urine at pH 4 to 5. Certain drugs, metabolites, or diagnostic agents may precipitate under these conditions. Of these methods, the heat test appears to be the most specific for protein. . Sensitivity is about 20-30 mg protein/d1 and the specificity appears better than with precipitation techniques. The strips are not affected by radiographic contrast media. (+) Alkaline urine. Urine must be highly buffered and strongly alkaline to overcome buffer action of the strips or tablets. Such interference is rarezol.
PROTEIN-BOUND IODINE (See thyroid function tests.}
PROTHROMBIN
Plasma prothrombin activity is estimated by means of the prothrombin clotting time. In the one-stage method, developed by Quick, oxalated plasma is mixed with excess thromboplastin and a predetermined amount of calcium ion. The time for clot formation is measured and compared with that for a normal control.
Alterations in clotting time associated with drug ad~nistration are not the result of test interferences, but rather arise from true changes in plasma levels of prothrombin, caused by interactions of other drugs with anticoagulants. The anticoagulants are carried in plasma bound to protein, mainly albumin, from which they can be displaced by competing drugs such as salicylates, phenylbutazone, oxyphenbutazone, indomethacin, and some sulfonamidesl. Increased amounts of active anticoagulant are thus made available and the prothrombin time is increased. Conversely, withdrawal of such drugs in a patient stabilized on anticoagulant therapy releases binding sites, leading to subsequent decrease in available anticoagulant, and a decrease in prothrombin time.
In addition, some drugs induce formation by the liver microsomes of enzymes which metabolize not only the drugs but other substrates. Barbiturates, for example, induce enzymes which metabolize coumarin, reducing its effect and decreasing prothrombin time. Sudden withdrawal of these drugs from patients stabilized on the drug and an anticoagulant may lead to a rapid and serious increase in prothrombin time, associated with a fall in prothrombin levels. These potentially serious interactions, which occur frequently but have often been unanticipated, are described thoroughly in recent reviews by Sigell and Flessa2*4 and by Koch-Weser and Sellers20".
1'9 TEST
Phenolsulfonphthalein (PSP, phenol red) is injected intravenously. The amount excreted in the urine during a timed interval provides an index of kidney function. The urine is made alkaline to develop a reddish-violet color which is measured spectrophotometrically. 
SPECIFIC GRAVITY (URINE)
(+) Radiographic contrast media 2os. We have observed urine specific gravities as high as 1.075 fo~o~v~g intravenous injection of diatrizoate (H~~aque).
T, AND T, TESTS (See thyroid function tests.)
THYMOL TURBIDITY
A buffered solution of thymol is mixed with serum. Increased turbidity is observed with serum from patients with hepatocellular damage, especially those with infectious hepatitis. (-) Heparin. Thymol turbidity, measured on either plasma or serum, decreased from 17 units to 3-5 units as heparin concentration was increased from zero to 0.5% (refs. 209, 210) . Thus, the effect appears to be related to heparin, rather than to differences in plasma and serum. We have observed failure to develop adequate turbidity in oxalated plasmas when compared to corresponding serums.
THYROID FUNCTION TESTS"
Methodology is discussed by Berger 211. The special problem of interference by iodine-containing substances has been reviewed by Rapport and Curtis212, and by Liewendah1213. In this section we have also included a number of pharmacologic effects since, in some cases, the exact mechanism of alteration of values is obscure. Either category of results could be misleading, when arriving at a diagnosis.
A. Protein-bound iodine (PBI). Serum proteins are precipitated and washed to remove inorganic iodine. Sodium carbonate is added, to minimize loss of iodine in the ashing step, and the precipitate is incinerated to destroy organic matter and to convert thyroxine iodine to inorganic iodide, which is quantitated by its catalytic effect on the ceric-arsenite reactionz?4. The Technicon procedure for automated determination substitutes digestion by a mixture of sulfuric, nitric, and perchloric acids for the alkaline ashing step. PBI procedures have been reviewed by Chaney*15. Davis21G, and recently AclandZ1', have reviewed the factors affecting the PBI test. Major classes of drug interference include iodine-containing compounds and substances which affect the amount of thyroxine (T4) in transport. (0) Acetazolamide.
No effect on test2r8.
(-) p-Aminobenzoate.
Antithyroid activity has been suggested219. (-) Aminoglutethimide.
Competes for T, binding sitesl.
(-) p-Aminosalicylate.
Antithyroid activity has been suggestedzzo-222. Bromides. Some preparations contain iodide as a contaminantzZO. Three of 6 patients given massive doses of potassium bromide-ammonium bromide showed elevated PBIZZ6. Busulfan. Normal PBI levels observed in z individuals following long-term administrationZZ7. Calcium. Calcium loading and subsequent withdrawal had no effect on test in 7 subjectsz2*. (-) Chlorpromazine.
Reports are conflicting. In one experiment, 5 patients given 600 mg/day showed an average decrease in PBI of 1.6 pg/dl. Ten patients given chlorpromazine and other drugs showed significantly increased T, turnoverZZ9. Antithyroid activi.ty has been suggested230.
(-) Chlorpropamide. Electrophoresis shows competition for TBG sitesZ31. Inhibits the ceric-arsenite reaction, probably by forming iodoauric acid. Gold is not removed in the dry ash stepZ51.
( ?) Hydrochlorothiazide.
One study found that the PBI was lowered, possibly due to a. true change252. Another study found that the PBI was unchanged21s. 
B. T,-by-cohmn.
Serum is acidified with pH 4.0 buffer to dissociate thyroxine (T4) from serum proteins, added to an anion exchange column, and washed with acid to remove proteins, iodotyrosines, and certain exogenous iodinated compounds. T+ iodothyronine (T3) and T4 are quantitatively eluted with concentrated acetic acid; iodine is liberated either by alkaline incineration or by direct bromination, and determined by its catalytic effect on the ceric-arsenite reaction. Inorganic iodide remains on the co1umn28g~290. Significant drug interference occurs with substances which affect the amount of thyroxine in transport and with certain iodine-containing compounds.
(-) Aminoglutethimide.
Competes for T4 binding site+. (-) Tolbutamide. Probably competes for binding sites231y285.
C. T4 by competitive protein b&d&g (CPB).
Ethanol is added to serum to precipitate proteins and extract the thyroxine. The alcohol extract is dried, and the residue is treated with a standard solution of normal serum in barbital buffer containing radio-iodine-labeled thyroxine. After equilibration, the unbound thyroxine is removed by gel filtration or by adsorption on ion exchange resin, and the bound radiothyroxine is counted. From the per cent bound ra~othyroxine, the total unlabeled thyroxine is found using a standard curve 291~292. Drugs whiich compete for binding sites act to decrease the total serum thyroxine level. If, however, the drug is extractable into ethanol, subsequent binding to TBG in the standard serum will increase the apparent T4 level in the unknown. (Barbital inhibits binding of T4 to TBPA and the serum is diluted suf&ciently in the method to minimize binding to TBA). CPB methods are considered to be more specific for thyroxine than either the PBI or T,-by-column test.
(-) Androgens, anabolic steroids. Decrease level of TBG, resulting in a true decrease in total TaZZ3 
The T, test (msatwated UzyzyroxiPze-b&ding gtob&n).
Serum is equilibrated with radioactive to-iodoth~on~e (T3) in the presence of a resin. The excess T,, adsorbed by the resin and counted, is inversely related to the concentration of unsaturated thyroxine-binding sites. In some methods'the supernatant is counted and expressed as unsaturated thyroxine-binding capacity or index of normal. In the tabulation below, we express results as T,uptake by resin; thus, high ?; values are found in hyperthyroidism and low T3 values in hypothyroidism. Drug interferences include substances which produce an alteration in the total number of binding sites and drugs which compete with T, for the available sites. 
E. Radioactive iodine uptake (RAIU).
Radioactive iodide is administered and, after the desired interval (usually 24 h), thyroidal radioactivity is measured by an external scintillation counter and expressed as a percentage of a standard sample measured in an identical manner. Factors influencing the test have been reviewed by GraysonZZO and by Magalotti et al. So0 Interferences are produced by drugs which alter . the size of the iodine pool, including iodinated organic compounds as well as inorganic iodine. The-effect of iodinated organic compounds is related to metabolic processes which result in continual release of inorganic iodine such as occurs following administration of iodinated radiographic contrast media. Drugs which displace thyroxine from its carrier proteins, producing an increase in free thyroxine, can cause a temporary decrease in thyroidal uptake of iodine due to suppressed thyroxine synthesis. (0) Acetazolamide. Drug produces no effect on test218. (-) p-Aminobenzoate. Antithyroid activity has been suggestedz19. Another report suggests that diuretics given at the time of the test may depress uptake values whereas after prolonged diuresis the RAIU may be elevated300. 
CARAWAY, KAMMEYER
(-) Vitamin A. Seven subjects were given 50000 IU orally per day for 21-27 days.
The 24-h RAW ranged from ~~-68% before administration, and decreased to 14-32% after administration, of the vitamin3~9.
TRANSAMINASE (GOT)
Serum glutamic oxaloacetic transaminase (GOT) catalyzes transfer of an amino group from aspartate to cc-ketoglutarate with formation of oxaloacetate and glutamate. Oxaloacetate is measured colo~met~cally after reaction with 2,4-~nitrophenyl-hydrazine or various azo dyes. For kinetic measurements, the reaction is coupled with NADH in the presence of malic dehydrogenase and the rate of disappearance of NADH is measured at 340 nm. Except as noted, the following refer to results obtained with the current method on the Technicon SMA 12160 in which oxaloacetate is dialyzed and reacted with Fast Ponceau L (diazotized ~-butyl-4-methoxymetaniIamide) according to Morgenstern et al. 310. The upper limit of normal is 40 units.
(+) Acetaminophen (APAP) ll. Pure solution of the drug reported to produce color with the dye.
(+) Acetoacetic acid 31L@2. Reacts with the dye to produce color and causes spurious elevation of GOT in patients with ketosis. Acetone and P-hydroxybutyric acid do not react. A solution containing 8.3 mg/dl increased the apparent GOT by 38 unit+%. No interference was encountered in the ultraviolet method nor with other coupling reagents tested312.
(+) +Aminosalicylatexl. Pure solution of the drug reported to produce color with the dye. (+) Ascorbic acid 11. A solution containing 250 ,ug/ml produced color equivalent to 32 units. The usual concentration of ascorbic acid in serum is about IO fag/ml at which level interference would be negligible.
(+) Erythromycin 314. Apparent GOT activity is elevated when either dinitrophenylhydrazine or a diazonium salt, azoene fast violet B, is used as color developer. The interfering substance is presumably a metabolite since erythromycin itself does not react. No interference was found with the ultraviolet kinetic method. (+) Levodopa. When given in doses of 3-7 g/day, apparent serum uric acid was falsely elevated by an average of 2076 and apparent urine uric acid was increased to 2-4 times the upper limit of normal. A dilute aqueous solution produced color in the reaction332. The ultraviolet method for uric acid was not affected. (+) Methyldopa. With usual oral dosage, plasma concentrations are negligible (z-3 pg/ml) but urinary excretion may amount to 250 mg/day8. We have observed that an aqueous solution of IO mgidl produced a color equivalent to approximately IO mg/dl of uric acid with the carbonate-phosphotungstate method.
(+) Phenacetin Il. Ingestion of 2 g of phenacetin or its metabolite, N-acetyl-p-aminophenol, increased apparent plasma uric acid by approximately I mg/dl after 2 to 4 h. Apparent concentration of uric acid in urine was increased z-fold. (+) Potassium ion. Produces turbidity with alkaline phosphotungstate. Plasma containing potassium salts of anticoagulants is unsuitable for uric acid determinations. (+) Salicylate. Gentisic acid, a metabolite, acts as a reducing agent383. Relatively high concentrations appear in urine but not in plasma. However, high concentrations of uricase-resistant chromogens have been noted in serum from patients with gout whose serum salicylate was maintained near 30 mg/d1334. Leads to low results if formalin is added as a preservative to specimens. False high results may be obtained if unknowns are compared to standards containing formalin.
UROBILTNOGEN (URINE}
Urobilinogen reacts with p-dimethylaminobenzaldehyde in acid solution (Ehrlich's aldchyde reagent) to produce a red color. Sodium acetate is added to reduce acidity, to intensify the color, and to inhibit color formation from indole. Porphobilinogen also reacts but will remain in the aqueous layer, in contrast to urobilinogen, after extraction with chloroform 336. An additional extraction with butanol is claimed to remove all of the known Ehrlich aldehyde compounds, except porphobilinogen, and forms the basis of a highly specific test for the latte?'. (+) p-Aminosalicplate 338. Urine from patients receiving this drug produces a red color with the reagent. (+) Bilirubin. Forms a green color under the reaction conditions and should be removed by treating the urine with barium chloride prior to performing the test.
(+) Chlorophyl1339. A metabolite, phylloerythrinogen, forms a dark red condensation product with the reagent. (+) Indolc+*. Present in normal urine and produces an orange-brown color with the 
